Recent advances in 3d-block metal complexes with bi, tri, and tetradentate Schiff base ligands derived from salicylaldehyde and its derivatives: Synthesis …
Schiff bases have been of continued interest in coordination chemistry for a long time
because they provide new ligand platforms that make reactivity easier and their metal …
because they provide new ligand platforms that make reactivity easier and their metal …
Zinc complexes with nitrogen donor ligands as anticancer agents
The search for anticancer metal-based drugs alternative to platinum derivatives could not
exclude zinc derivatives due to the importance of this metal for the correct functioning of the …
exclude zinc derivatives due to the importance of this metal for the correct functioning of the …
Chemical, physical, and biological properties of Pd(II), V(IV)O, and Ag(I) complexes of N3 tridentate pyridine-based Schiff base ligand
LH Abdel-Rahman, AM Abu-Dief, FM Atlam… - Journal of …, 2020 - Taylor & Francis
A new N3-tridentate imine ligand, 2, 6-diacetylpyridinediphenylhydrazone (DAPH)(L), and
its Pd (II), V (IV) O, and Ag (I) complexes were synthesized and characterized via elemental …
its Pd (II), V (IV) O, and Ag (I) complexes were synthesized and characterized via elemental …
Metal Complexes in cancer treatment: Journey so far
A Kumar Singh, A Kumar, H Singh… - Chemistry & …, 2023 - Wiley Online Library
Metal complexes in cancer therapy have attracted much interest mainly because metals
exhibit unique characteristics, such as redox activity, metal‐ligand interaction, structure and …
exhibit unique characteristics, such as redox activity, metal‐ligand interaction, structure and …
Copper complexes with 1, 10-phenanthroline derivatives: Underlying factors affecting their cytotoxicity
P Nunes, I Correia, F Marques, AP Matos… - Inorganic …, 2020 - ACS Publications
The interpretation of in vitro cytotoxicity data of Cu (II)-1, 10-phenanthroline (phen)
complexes normally does not take into account the speciation that complexes undergo in …
complexes normally does not take into account the speciation that complexes undergo in …
Copper complexes as artificial DNA metallonucleases: from Sigman's reagent to next generation anti-cancer agent?
TJP McGivern, S Afsharpour, CJ Marmion - Inorganica Chimica Acta, 2018 - Elsevier
Platinum drugs continue to dominate medical oncology treatments but they have
shortcomings associated with their use including dose-limiting toxic side effects and …
shortcomings associated with their use including dose-limiting toxic side effects and …
Water-soluble dioxidovanadium (V) complexes of aroylhydrazones: DNA/BSA interactions, hydrophobicity, and cell-selective anticancer potential
G Sahu, A Banerjee, R Samanta, M Mohanty… - Inorganic …, 2021 - ACS Publications
Five new anionic aqueous dioxidovanadium (V) complexes,[{VO2L1, 2} A (H2O) n] α (1–5),
with the aroylhydrazone ligands pyridine-4-carboxylic acid (3-ethoxy-2-hydroxybenzylidene) …
with the aroylhydrazone ligands pyridine-4-carboxylic acid (3-ethoxy-2-hydroxybenzylidene) …
Therapeutic potential of vanadium complexes with 1, 10-phenanthroline ligands, quo vadis? Fate of complexes in cell media and cancer cells
P Nunes, I Correia, I Cavaco, F Marques… - Journal of Inorganic …, 2021 - Elsevier
Abstract V IV O-complexes formulated as [V IV O (OSO 3)(phen) 2](1)(phen= 1, 10-
phenanthroline),[V IV O (OSO 3)(Me 2 phen) 2](2)(Me 2 phen= 4, 7-dimethyl-1, 10 …
phenanthroline),[V IV O (OSO 3)(Me 2 phen) 2](2)(Me 2 phen= 4, 7-dimethyl-1, 10 …
Health benefits of vanadium and its potential as an anticancer agent
DC Crans, L Yang, A Haase, X Yang - Met. Ions Life Sci, 2018 - degruyter.com
Vanadium compounds have been known to have beneficial therapeutic properties since the
turn of the century, but it was not until 1965 when it was discovered that those effects could …
turn of the century, but it was not until 1965 when it was discovered that those effects could …
New VIV, VIVO, VVO, and VVO2 Systems: Exploring their Interconversion in Solution, Protein Interactions, and Cytotoxicity
The synthesis and characterization of one oxidoethoxidovanadium (V)[VVO (L1)(OEt)](1)
and two nonoxidovanadium (IV) complexes,[VIV (L2–3) 2](2 and 3), with aroylhydrazone …
and two nonoxidovanadium (IV) complexes,[VIV (L2–3) 2](2 and 3), with aroylhydrazone …